Hepatology
From the Journals
Aspirin cuts risk of ovarian and liver cancer
Regular aspirin use decreased the risk of both ovarian cancer and hepatocellular carcinoma.
Conference Coverage
Black patients present as sicker, more likely to receive liver transplant
PHILADELPHIA – Black patients with acute liver failure were more likely to be wait-listed, listed as status 1, and...
From the Journals
Myeloperoxidase elevated in HCV-related liver cancer
Marked expression of myeloperoxidase is associated with the pathogenesis of HCV-related hepatocellular carcinoma.
Conference Coverage
Opiate use tied to hepatitis C risk in youth
SAN FRANCISCO – A large, nationwide survey suggests the need for more hepatitis C virus testing among adolescents and young adults with opiate use...
From the Journals
Cirrhosis study finds no link between screening, liver cancer mortality
Among patients with cirrhosis, screening for hepatocellular carcinoma was not associated with reductions in liver cancer mortality.
From the Journals
Transition to noninjected drug use lowers risk of HCV infection
From the Journals
Even modest alcohol use may worsen NAFLD
Modest alcohol consumption was associated with significantly less improvement in steatosis and significantly lower odds of NASH resolution.
Conference Coverage
Prepare for ‘the coming tsunami’ of NAFLD
NEW ORLEANS – It’s time for primary care physicians to stop ignoring NASH, an expert says.
From the Journals
Weight gain linked to progression of fibrosis in NAFLD patients
Degree of weight change was associated with risk of fibrosis progression; those who lost weight reduced their risk.
News from the FDA/CDC
Liver cancer death rates down for Asians and Pacific Islanders
Long-term decrease bucks the larger trend of rising rates.
From the Journals
Deaths from liver disease surged in U.S. since 1999
Deaths from cirrhosis increased by 65.4% and deaths from hepatocellular carcinoma by 117%.